|Marrone Bio Innovations, Inc.|
2121 Second Street
United States - Map
Marrone Bio Innovations, Inc. provides bio-based pest management and plant health products for the crop protection, water treatment, and other target markets in the United States and internationally. The company offers crop protection products, including herbicides for weed control; fungicides for plant disease control; nematicides for parasitic roundworm control; insecticides for insect and mite killers; and plant growth regulators, which growers use to increase crop yields, enhance plant health, manage pest resistance, and reduce chemical residues. It also provides water treatment products for invasive water pests in a range of applications comprising hydroelectric and thermoelectric power generation, industrial applications, drinking water, aquaculture, irrigation, and recreation. The companys products include Regalia, a plant extract-based fungicidal biopesticide for plant disease control and plant health; Grandevo, a bioinsecticide for insect and mite control to the growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens, and ornamental plants; and Zequanox, a biomolluscicide that kills invasive mussels, which cause infrastructure and ecological damage primarily to power and industrial companies. Its products also include Opportune, a bioherbicide that kills weeds; and Venerate, a bioinsecticide, which kills a range of chewing and sucking insects and mites, as well as flies and plant parasitic nematodes. Marrone Bio Innovations, Inc. offers its products directly, as well as through distributors. The company, formerly known as Marrone Organic Innovations, Inc., was founded in 2006 and is headquartered in Davis, California.
|Dr. Pamela G. Marrone Ph.D.,
Founder, Chief Exec. Officer, Pres and Director
|Mr. Hector M. Absi ,
|Mr. James B. Boyd ,
Chief Financial Officer, Principal Accounting Officer, VP and Sec.
|Dr. Alison Stewart Ph.D., CNZM, FNZIAHS, FAPPS,
Chief Technology Officer and Sr. VP of R&D
|Ms. Linda V. Moore ,
Chief Compliance Officer, VP and Gen. Counsel
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|